Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1950285
Max Phase: Preclinical
Molecular Formula: C52H69N7O14S2
Molecular Weight: 1080.29
Molecule Type: Small molecule
Associated Items:
ID: ALA1950285
Max Phase: Preclinical
Molecular Formula: C52H69N7O14S2
Molecular Weight: 1080.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)C1OC1C(=O)N(CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)CCCCCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21
Standard InChI: InChI=1S/C52H69N7O14S2/c1-7-56-38-26-24-34(74(66,67)68)31-36(38)51(3,4)41(56)20-12-9-13-21-42-52(5,6)37-32-35(75(69,70)71)25-27-39(37)57(42)29-17-11-14-22-44(61)54-28-16-10-15-23-45(62)58-30-18-19-40(58)48(63)55-59(33-43(53)60)49(64)46-47(73-46)50(65)72-8-2/h9,12-13,20-21,24-27,31-32,40,46-47H,7-8,10-11,14-19,22-23,28-30,33H2,1-6H3,(H5-,53,54,55,60,61,63,66,67,68,69,70,71)/t40-,46?,47?/m0/s1
Standard InChI Key: ULWTXUNODKMJAW-CBWOAKADSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1080.29 | Molecular Weight (Monoisotopic): 1079.4344 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lee J, Bogyo M.. (2012) Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain., 22 (3): [PMID:22243962] [10.1016/j.bmcl.2011.12.079] |
Source(1):